These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14623961)

  • 1. Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis.
    Mourez M; Yan M; Lacy DB; Dillon L; Bentsen L; Marpoe A; Maurin C; Hotze E; Wigelsworth D; Pimental RA; Ballard JD; Collier RJ; Tweten RK
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13803-8. PubMed ID: 14623961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of new dominant-negative mutants of anthrax protective antigen using directed evolution.
    Wu G; Feng C; Cao S; Guo A; Liu Z
    Appl Biochem Biotechnol; 2012 Nov; 168(5):1302-10. PubMed ID: 22948605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane insertion by anthrax protective antigen in cultured cells.
    Qa'dan M; Christensen KA; Zhang L; Roberts TM; Collier RJ
    Mol Cell Biol; 2005 Jul; 25(13):5492-8. PubMed ID: 15964805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to characterizing single-subunit mutations in multimeric prepores and pores of anthrax protective antigen.
    Janowiak BE; Finkelstein A; Collier RJ
    Protein Sci; 2009 Feb; 18(2):348-58. PubMed ID: 19165720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.
    Sun J; Lang AE; Aktories K; Collier RJ
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4346-51. PubMed ID: 18334631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of dominant-negative forms of anthrax protective antigen.
    Yan M; Collier RJ
    Mol Med; 2003; 9(1-2):46-51. PubMed ID: 12765339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo.
    Singh Y; Khanna H; Chopra AP; Mehra V
    J Biol Chem; 2001 Jun; 276(25):22090-4. PubMed ID: 11278644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthrax protective antigen: prepore-to-pore conversion.
    Miller CJ; Elliott JL; Collier RJ
    Biochemistry; 1999 Aug; 38(32):10432-41. PubMed ID: 10441138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation.
    Wimalasena DS; Cramer JC; Janowiak BE; Juris SJ; Melnyk RA; Anderson DE; Kirk KL; Collier RJ; Bann JG
    Biochemistry; 2007 Dec; 46(51):14928-36. PubMed ID: 18044973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.
    Cunningham K; Lacy DB; Mogridge J; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7049-53. PubMed ID: 11997439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.
    Zhang J; Xu J; Li G; Dong D; Song X; Guo Q; Zhao J; Fu L; Chen W
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1164-71. PubMed ID: 16460675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of residues constituting the 2beta1 strand of domain II in the biological activity of anthrax protective antigen.
    Khanna H; Chopra AP; Arora N; Chaudhry A; Singh Y
    FEMS Microbiol Lett; 2001 May; 199(1):27-31. PubMed ID: 11356563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.
    Salles II; Voth DE; Ward SC; Averette KM; Tweten RK; Bradley KA; Ballard JD
    Cell Microbiol; 2006 Aug; 8(8):1272-81. PubMed ID: 16882031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane translocation by anthrax toxin.
    Collier RJ
    Mol Aspects Med; 2009 Dec; 30(6):413-22. PubMed ID: 19563824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin.
    Mogridge J; Mourez M; Collier RJ
    J Bacteriol; 2001 Mar; 183(6):2111-6. PubMed ID: 11222612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.
    Jacquez P; Avila G; Boone K; Altiyev A; Puschhof J; Sauter R; Arigi E; Ruiz B; Peng X; Almeida I; Sherman M; Xiao C; Sun J
    PLoS One; 2015; 10(6):e0130832. PubMed ID: 26107617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.